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SIGNIFICANCE
The amount of training needed to correctly interpret optical 
coherence tomography, a promising technique in diagnos­
ing basal cell carcinoma, is not defined. This study used cu­
mulative sum analysis to determine how many optical co­
herence tomography scans should be evaluated by novice 
assessors in order to obtain competence in diagnosing ba­
sal cell carcinoma. Four hundred lesions suspect for non- 
melanoma skin cancer were evaluated. Acceptable perfor­
mance was reached after assessing 183–311 scans. How-
ever, the number of scans needed for training depends on 
the standards one sets to achieve. Cumulative sum analysis 
has proven to be a comprehensible method in monitor ing a 
trainee’s performance.
The amount of training needed to correctly interpret 
optical coherence tomography scans of the skin is un­
defined. The aim of this study was to illustrate how 
cumulative sum charts can be used to determine how 
many optical coherence tomography scans novice as­
sessors should evaluate in order to obtain competence 
in diagnosing basal cell carcinoma. Four hundred lesions 
suspected for non-melanoma skin cancer were evaluat-
ed by optical coherence tomography in combination 
with clinical photographs, using a 5-point confidence 
scale. The diagnostic error rate (sum of false-negative 
and false­positive optical coherence tomography 
results/total number of cases) was used to evaluate 
performance, with histopathological diagnosis as the 
reference standard. Acceptable and unacceptable error 
rates were set at 16% and 25%, respectively. Adequate 
performance was reached after assessing 183–311 
scans, dependent on the cut-off for a positive test 
result. In conclusion, cumulative sum analysis is use­
ful to monitor the progress of optical coherence tomo­
graphy trainees. The caseload necessary for training is 
substantial.
Key words: optical coherence tomography; basal cell carcino­
ma; diagnostic; non­invasive; cumulative sum analysis; lear­
ning curve.
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The incidence of keratinocyte carcinoma has in­creased over the past decades, with basal cell car­
cinoma (BCC) being the most prevalent cancer in the 
Caucasian population worldwide (1–3). Diagnosis of 
BCC is often confirmed histopathologically by a biopsy, 
which also allows BCC subtyping and accommodates 
choice of the most appropriate treatment (4). Biopsies 
are invasive, may be painful, and can be complicated 
by, for example, bleeding (5). Moreover, histological 
assessment takes time, and treatment may only be start­
ed following a second consultation. In recent years, 
non­invasive diagnostic techniques have improved and 
interest in their application for skin cancer is comprehen­
sively growing. Optical coherence tomography (OCT) 
was first described as a potential imaging method for 
dermatology in 1997 (6). It relies on the reflection of 
light to obtain cross­sectional images of tissue, with an 
axial resolution of approximately 15 μm and a detection 
depth of approximately 1.5 mm (7) Real­time, in vivo 
images of tissue microarchitecture are provided. For 
BCC, morphological features on OCT have been defined 
that show high concordance with regular histopathology 
slides (8–11). Several studies have explored the diag­
nostic value of OCT for discrimination between BCC 
and other diagnoses, and have reported high sensitivity 
(≥ 80%), with specificity ranging from 75% to 96% 
(12–15). Higher diagnostic accuracy has been described 
for more experienced observers (12, 16). However, data 
on learning curves for interpretation of OCT images is 
not available, whilst this is valuable information for 
physicians who are considering working with OCT. The 
learning curve for OCT­assisted diagnosis of BCC was 
studied using cumulative sum (CUSUM) analysis. The 
aim of this study was to illustrate how CUSUM charts 
can be used to determine how many OCT scans have 
to be evaluated by novice assessors in order to achieve 
an adequate level of competence in distinguishing BCC 
from other diagnoses. 
MATERIALS AND METHODS
The research database of a prospective observational cohort study, 
initiated at the outpatient clinic of the Dermatology Department of 
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Maastricht University Medical Centre+ (MUMC+), Maastricht, 
the Netherlands, was used (17). The study was approved by the 
Medical Ethical Committee of MUMC+. 
Patients, age 18 years or older, receiving a skin biopsy of a 
lesion clinically suspect for a keratinocyte carcinoma or pre­
malignancy, were included between 15 February and 29 June 
2017. Written informed consent was obtained. Exclusion criteria 
were: patients who were unable to sign informed consent. The 
physician marked the area for biopsy and clinical and (if ordered 
by the physician) dermoscopic pictures were taken by a medical 
photographer. The marked biopsy area was scanned with OCT 
(VivoSight OCT, Michelson Diagnostics, Maidstone, UK) and 
consecutively a 3­mm punch biopsy was taken. Histopathology 
was assessed by independent pathologists, who were unaware of 
the OCT diagnosis.
OCT images were coded and saved anonymously. OCT assess­
ment was performed by 2 researchers who evaluated the clinical 
(and if available, dermoscopic) pictures in conjunction with the 
OCT images. Assessment of the OCT images on presence of BCC 
was based on the criteria described by Hussain et al. and the Vivo­
Sight online atlas (http://www.vivosightatlas.com/) (Table I) (8, 
18). Level of confidence in the diagnosis of BCC was documented 
using a 5-point Likert-scale (range 0–4, Table II).
The OCT assessors reached consensus on each OCT scan and 
were unaware of the histopathological results before making a 
final diagnosis. In order to accommodate the learning process, the 
assessors received immediate feedback of the histopathological 
outcome after each scan for the first 100 scans. For the remaining 
cases in the database, feedback on histopathological outcome was 
given after every 10–15 scans. 
The diagnostic error rate, defined as the sum of false-negative 
and false­positive OCT results as a proportion of the total number 
of cases, was used as the criterion to assess diagnostic performance 
in this study, with histopathological diagnosis as reference standard. 
Training prior to the study
Before the start of the study, the OCT assessors received in­
structions on BCC diagnosing and subtyping with OCT by a 
representative from the manufacturer. Also they studied literature 
on OCT in dermatology and attended a convention on OCT (19). 
Approximately 20 OCT scans were assessed purely for educational 
purposes and to become familiar with the OCT device (scans not 
included in this study).
One of the OCT assessors had several years of clinical expe­
rience with diagnosis and treatment of BCC (including Mohs 
surgery) as a dermatology resident, and one had two years of 
experience in clinical dermato­oncology as a research fellow.
Learning curve analysis 
A cumulative sum (CUSUM) chart was used to track performance 
over time and was constructed using an Excel spreadsheet (20). 
CUSUM is an analysis technique typically used for sequential 
monitoring of cumulative performance and detection of change in 
performance over time. CUSUM charts were originally developed 
for industrial process monitoring and are based on the classification 
of a product’s quality into 1 of 2 categories: “defective” or “non­
defective” (21). The purpose is to detect changes in the proportion 
(p) of items in the “defective” category. It is necessary to pre­specify 
an acceptable failure rate (p0) and an unacceptable failure rate 
(p1). In the same manner, a CUSUM chart can be applied to eva­
luate the learning process in medical interventional and diagnostic 
techniques (20, 22–25). The outcome of the diagnostic technique 
(in this case OCT) has to be classified into “success” or “failure”. 
For construction of the CUSUM chart, the cumulative sum after 
each case is plotted against the index number of that case. For each 
failure, a certain score (s, see formula in Appendix S11) is added 
and for each success, a score (1 – s) is subtracted. The CUSUM 
is the running sum of a mixture of increments (with each failure) 
and decrements (with each success). A continuing descending 
curve indicates that successes occur more frequently than failures.
When the running sum exceeds a certain threshold boundary, 
this signals a critical change. The upper and lower limits represent 
the boundary above which performance becomes unacceptable 
(h0) or below which performance becomes acceptable (h1), re­
spectively. These boundaries depend on the setting of p0 and p1, 
but also on the setting of the false-positive or type I error (α, risk 
of falsely concluding that a trainee’s performance is unacceptable 
when it is not) and the false-negative or type II error (β, the risk 
of falsely concluding that a trainee’s performance is acceptable 
when it is not). The type I and type II error are conventionally 
set at 0.1, making h0 and h1 equal (22). For a detailed explanation 
see Appendix S11. 
The primary endpoint in this study was the number of OCT 
assessments after which an adequate level of competence was 
achieved. A cut-off value of the confidence score in the OCT 
diagnosis has to be chosen to define positive and negative test 
results. CUSUM curves were made using 2 alternative cut­off 
values; ≥ 2 and ≥ 3 on the Likert scale (Table II). All diagnoses 
were compared with the histopathological diagnosis. 
The acceptable diagnostic error rate was set at 16% and the 
unacceptable error rate at 25%.
Table I. Criteria used for assessing optical coherence tomography 
(OCT) images on presence and subtyping of basal cell carcinoma 
Presence of basal cell carcinoma
• Disruption of layering
• Hyporeflective ovoid structures 
• Dark areas surrounded by a hyper-reflective halo
• Peritumoural white/refractile stroma
• Palisading at margin
• Necrosis
• Widened epidermis
Adapted from Hussain et al. (8) and https://www.vivosightatlas.com/category/
basal-cell-carcinoma/.
Table II. Level of confidence in diagnosis of basal cell carcinoma (BCC) on optical coherence tomography (OCT) and definition of positive 
and negative OCT test results according to 2 different cut-off values of the confidence score
Level of confidence
Cut-off value of confidence score for a positive test result
Cut-off ≥2 Cut-off ≥3
0: Certainly no BCC No BCC (negative test result) No BCC (negative test result)
1: Low suspicion of BCC No BCC (negative test result) No BCC (negative test result)
2: High suspicion of BCC, other diagnosis may be possible BCC (positive test result) No BCC (negative test result)
3: Certain of BCC diagnosis, unsure of subtype BCC (positive test result) BCC (positive test result)
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RESULTS
A total of 400 OCT scans with corresponding clinical 
images of 400 lesions in 289 patients were included. 
All lesions were clinically suspicious for keratinocyte 
carcinoma or pre-malignancy. Of all 289 patients, 208 
had 1 lesion, 63 patients had 2 lesions, 10 patients had 
3 lesions, 6 patients had 4 lesions, and 2 patients had 6 
lesions. Lesion characteristics are presented in Table III. 
Histopathology results revealed a total of 192 BCCs and 
208 other diagnoses. 
When using a cut-off value ≥ 2, high suspicion of BCC 
(score 2) as well as certainty of the presence of BCC (scores 
3 and 4) are defined as a test-positive result of OCT. There 
were 23 false-negative diagnoses and 40 false-positive 
diagnoses, corresponding to an overall error rate of 15.8% 
(63/400). The CUSUM curve is presented in Fig. 1. 
From case 55 onwards the curve starts declining, and 
definitively crosses the acceptable boundary (h1) from 
above at case number 183. This crossing signals that 
the hypothesis, that acceptable performance at the pre­
set error rate of 16% has been reached, can be accepted 
(with α=0.1 and β=0.1). The CUSUM curve continues to 
decline, indicating that performance remains acceptable.
When using a cut-off value ≥ 3, only certainty of BCC 
presence on OCT is defined as a positive test result. 
There were 48 false­negative and 26 false­positive OCT 
diagnoses corresponding to an overall error rate of 18.5% 
(74/400). The curve initially courses around and above 
the x­axis, indicating a “trial and error” state until case 
52 (Fig. 1). It first crosses the acceptable boundary (h1) 
from above at case 202, but subsequently fluctuates 
around the critical h­line, giving it an overall horizontal 
course to definitely cross it from above at case 311. At 
this point, the hypothesis that the diagnostic error rate 
reached 16%, can be accepted. 
DISCUSSION
This study illustrates how the CUSUM method can be 
used to create learning curves and estimate after how 
many OCT scans diagnostic performance meets pre­
specified standards.
Learning curves graphically show the relationship 
between learning effort and achievement. The benefit of 
CUSUM is that it continuously assesses individual per­
formance and progress in mastering a new technique (20). 
It also serves as a rapid detector of change and allows 
for early intervention, such as retraining or continued 
observation, which is especially useful in its applica­
tion in trainee programmes (26, 27). It has become an 
accepted method for monitoring performance in medical 
therapeutic and diagnostic procedures (20, 24, 28, 29). 
The diagnostic error rate can be used as a measure for 
overall diagnostic performance in learning curves (20). 
This rate does not distinguish be­
tween sensitivity and specificity, 
which are discussed in another 
paper (17). 
The OCT trainees reported 
their diagnosis on a 5­point con­
fidence scale, which enabled 
us to monitor performance for 
different thresholds for a posi­
tive test result for OCT. Since a 
score of 3 or more on the Likert 
scale reflected the assessor being 
certain of the diagnosis BCC, 
we considered this as the most 
appropriate threshold. How ever, 
in a scenario in which the aim is 
not to miss a BCC, one may opt 
for a confidence level ≥ 2 as the 
cut­off point for a positive test 
result. For the latter, the number 
of cases (n = 183) that need to be 
Table III. Characteristics of the 400 lesions included in the study
Characteristics
Location, n (%)
  Head and neck area 186 (46.5)
  Trunk 123 (30.8)
  Extremities   91 (22.8)
Diagnosis, n (%)
  Basal cell carcinoma 192 (48.0)
  Actinic keratosis 42 (10.5)
  Morbus Bowen 24 (6.0)
  Squamous cell carcinoma 29 (7.3)
  Melanoma or lentigo maligna   2 (0.5)
  Other malignant   6 (1.5)
  Benign naevoid 13 (3.3)
  Other benign tumours 34 (8.5)
  Inflammatory 36 (9.0)
  Inconclusive diagnosis   6 (1.5)
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Fig. 1. Cumulative sum (CUSUM) curve for optical coherence tomography (OCT)-assisted 
diagnosis of basal cell carcinoma (BCC) (n = 400), with p0 = 16% and p1 = 25% for cut-off value 
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evaluated before reaching acceptable performance was 
lower than the 311 required scans when the more strict 
threshold ≥ 3 was used. A possible explanation is that less 
experienced OCT users tend to exercise more caution in 
their judgement, represented by lower confidence scores, 
which is penalized when using a high confidence score 
as the cut­off value.
When the ultimate goal of OCT is to be able to omit 
punch biopsy, it becomes important to monitor the ability 
to make both accurate and confident diagnoses. However, 
such ability requires more and longer training. 
The number of cases required to achieve acceptable 
performance depends strongly on the choice of the ac­
ceptable and unacceptable failure rates (p0 and p1). These 
parameters set the target that one wants to achieve and 
may differ between centres. However, the setting of 
realistic targets for our centre, where OCT has not yet 
been implemented in clinical practice, was challenging. 
Diagnostic error rates of 12% have been reported by 2 
(industry­initiated) studies on diagnostic performance 
of OCT (13, 14). However, the prevalence of BCC was 
higher than in the current study, and thus the study po­
pulations may represent a different case mix. Moreover, 
the level of confidence in the OCT diagnosis used to 
define a positive test result with OCT was not explicitly 
reported in these studies (13, 14). Therefore, efforts 
were made to obtain an estimate of the failure rate of 
a competent, experienced operator. For this purpose, 2 
OCT users with 23 and 8 years of experience (JW and 
SS) assessed a randomly chosen subset of 100 scans 
from our database. The error rates of these OCT users 
were 16%. The setting of the unacceptable error rate at 
25% was more straightforward, since this was the error 
rate accomplished by clinical examination in this study 
and, in order to be of added value, we considered that 
OCT­assisted diagnosis should not exceed this rate (17).
This study gives an indication of the number of 
cases that, given our clinical, histopathological and 
OCT experience, need to be assessed with OCT before 
being able to discriminate BCC from other diagnoses. 
However, these results cannot be universally applied to 
other centres, because previous experience with OCT 
may differ, as well as targets considered feasible or ac­
ceptable. In former studies, OCT training programmes 
(if described) consisted of a 30-min instruction with 50 
OCT images or a 20-min lecture on OCT (12, 16). In the 
current study, training was more extensive. We consider 
that a basic level of background knowledge is neces­
sary in order to understand the structures visible on the 
scans and a similar 2­day course, consisting of general 
lectures and hands­on training by experienced users, is 
minimally required before starting to train with OCT in 
clinical practice. 
In conclusion, currently, no recommendations or 
guide lines on training in OCT exist. This study illustrates 
our experience with how a learning curve can help to 
establish the number of cases that are required to achieve 
an adequate level of performance. At an acceptable and 
unacceptable diagnostic error rate of 16% and 25%, 
adequate performance in diagnosing BCC was reached 
after 183–311 scans. In conclusion, a substantial number 
of scans need to be evaluated to achieve adequate com­
petence in diagnosing BCC with OCT. 
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